Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis

Status:
Completed

Trial end date:
2018-04-24

Target enrollment:

Participant gender:

To compare the safety and efficacy profiles of AM001 Cream, 7.5% and its vehicle cream in the treatment of Actinic Keratosis (AK) Lesions

Phase 2

AmDerma